Global Study Asset Manager

Clearline Recruitment Ltd; Welwyn Garden City; Hybrid; GBP 88,000 - 98,000; Full time

Benefits offered by this job

25 days holiday plus Bank Holidays

Hybrid working with home working Flex

Minimum 2-3 days per week in the офис

Job summary

Clearline Recruitment Ltd is assisting a leading global healthcare organisation in recruiting a Global Study Asset Manager. The role is based in Welwyn Garden City, offering hybrid working with 2–3 days in the office and a 6-month contract inside IR35.

You will oversee the operational delivery of a portfolio of global clinical studies, engage with CROs, vendors and cross‑functional teams, and ensure study plans align with ICH-GCP and regulatory requirements.

Qualifications

• Significant clinical study management experience within global trials.
• Strong knowledge of ICH-GCP and drug development process.
• Experience overseeing CROs, vendors and cross-functional stakeholders.
• Ability to manage study timelines, quality, risks and KPIs.
• Experience leading operations from planning to database lock.
• Comfort operating in a fast-paced global environment.

Responsibilities

• Coordinate operational delivery of multiple studies within an asset portfolio.
• Ensure studies progress in line with ICH-GCP, SOPs and study plans.
• Support development of key study documents and operational plans.
• Manage study recruitment expectations and forecasting.
• Oversee study performance, quality, timelines, risks and KPIs.
• Partner closely with CROs and internal global study teams.
• Lead third-party vendor selection, set-up, oversight and close-out.
• Maintain inspection readiness.
• Manage IMP supply and shipment where required.
• Drive operational improvements and efficiencies across studies.

Skills

Global study management

Global clinical trials

ICH-GCP knowledge

CRO/vendor oversight

Study delivery

Stakeholder management

Education

Life Sciences degree

Equivalent experience

Job description

Role: Global Study Asset Manager

Location: Welwyn Garden City (Hybrid - 2/3 days in office)

Hours: Full-time, 37.5 hours per week

Contract: 6 months, Inside IR35

Pay: £339.27 - £376.97 per day PAYE basic or £450 - £500 per day Umbrella

An excellent opportunity has arisen for a highly experienced Global Study Asset Manager to join one of our longstanding clients, a leading global healthcare organisation.

This is a senior clinical operations role responsible for the operational delivery of a portfolio of global clinical studies, working across internal study teams, CROs, vendors and cross-functional stakeholders.

Benefits

• 25 days holiday plus Bank Holidays
• Hybrid working with home working flexibility
• Minimum 2-3 days per week in the office
• Free onsite parking
• Opportunity to work within a leading global healthcare organisation
• Exposure to complex, global clinical studies

The Requirements

• Significant clinical study management experience within global clinical trials
• Strong clinical operations and study delivery experience
• Phase III experience is essential
• Strong knowledge of the drug development process, ICH and GCP
• Experience managing studies from operational planning through to database lock
• Experience overseeing CROs, vendors and cross-functional stakeholders
• Strong understanding of study timelines, quality, risks and KPIs
• Life Sciences degree or equivalent experience preferred
• Confident operating in a fast-paced, complex global environment

The Role

• Coordinate the operational delivery of multiple studies within an asset portfolio
• Ensure studies progress in line with ICH-GCP, SOPs and study plans
• Support development of key study documents and operational plans
• Manage study recruitment expectations and forecasting
• Oversee study performance, quality, timelines, risks and KPIs
• Partner closely with CROs and internal global study teams
• Lead third-party vendor selection, set-up, oversight and close-out
• Maintain inspection readiness
• Manage IMP supply and shipment where required
• Drive operational improvements and efficiencies across studies